Qianya Peng

机构：Meizhou City People's Hospital

发表论文 2 篇 · 总被引 36 次 · h-index 1

代表论文

• CRISPR/Cas9-based gene-editing technology for sickle cell disease (2023 · Gene · 被引 36)
• Sorafenib Combined with DOAP Regimen for the Treatment of BRAF V600E-Negative Langerhans Cell Sarcoma: A three-year follow-up result (2024)